This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Flagship Pioneering Innovations V, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Alexandra Masu Cantley: Innovator in Immune Modulation
Introduction
Alexandra Masu Cantley is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of immunology through her innovative research and patented methods. Her work focuses on modulating immune activity, which has important implications for treating infections and cancer.
Latest Patents
Alexandra holds a patent for "Methods of modulating immune activity." This invention provides methods for increasing immune response by administering postcellular signaling factors produced by cells exposed to stress conditions. It also includes methods for increasing immune response through the combination of a Stimulator of Interferon Genes (STING) agonist and a purinergic receptor agonist. Additionally, her invention outlines screening assays for identifying compounds that induce the production of immunostimulatory agents. Furthermore, it offers methods for decreasing immune response by administering purinergic receptor antagonists.
Career Highlights
Alexandra is associated with Flagship Pioneering Innovations V, Inc., where she continues to advance her research in immune modulation. Her innovative approaches have garnered attention in the scientific community, contributing to the understanding of immune responses.
Collaborations
She has collaborated with notable colleagues, including Anthony Michael Barsotti and Douglas Gowers Cole, to further her research and development efforts in the field.
Conclusion
Alexandra Masu Cantley's work in immune modulation represents a significant advancement in medical science. Her patented methods have the potential to improve treatment options for various diseases, showcasing her role as a leading innovator in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
